• Methylprednisolone: Synthetic Glucocorticoid Receptor Agonis

  2026-06-12

  Methylprednisolone enables precise modeling of glucocorticoid-induced tissue injury, streamlining both in vitro and in vivo anti-inflammatory assays. This guide details experimental workflows, troubleshooting, and translational insights from recent osteonecrosis research to help researchers maximize reproducibility and impact.

• Schisandra Decoction Modulates Autophagy in Parkinson’s Dise

  2026-06-11

  Pan et al. provide robust evidence that Schisandra Decoction (Sch D) alleviates motor deficits and reduces pathological α-synuclein accumulation in a mouse model of Parkinson’s disease by modulating the PI3K/AKT/mTOR signaling pathway. This work highlights autophagy regulation as a neuroprotective mechanism, with translational implications for gene expression analysis in neurodegeneration.

• Streptavidin-FITC: Precision Biotin Detection for Traffickin

  2026-06-11

  Leverage Streptavidin-FITC for ultra-sensitive, specific detection of biotinylated molecules in workflows from immunohistochemistry to advanced intracellular trafficking analysis. This guide demystifies protocol optimization and experimental troubleshooting, translating the latest reference findings into actionable strategies for robust biotin-streptavidin binding assays.

• lncRNA PART1 Regulates Ovarian Cancer via miR-503-5p/FOXK1 A

  2026-06-10

  Li et al. (2022) elucidate a novel regulatory pathway in ovarian cancer, demonstrating that lncRNA PART1 promotes tumor viability, migration, and invasion by modulating the miR-503-5p/FOXK1 axis. Their integrative use of molecular and cellular assays provides a mechanistic basis for targeting PART1 as a potential therapeutic strategy.

• Praeruptorin A Suppresses NF-κB Activation in Macrophages

  2026-06-10

  This study demonstrates that Praeruptorin A, a coumarin from Peucedanum praeruptorum, inhibits NF-κB pathway activation and inflammatory gene expression in poly (I:C)-stimulated RAW264.7 macrophages. The findings highlight the utility of natural product modulators for dissecting innate immune signaling and identifying anti-inflammatory strategies.

• HotStart Universal 2X Green qPCR Master Mix: Precision in Ge

  2026-06-09

  The HotStart Universal 2X Green qPCR Master Mix streamlines dye-based real-time PCR, ensuring unmatched specificity and reproducibility for gene expression quantification—even in challenging neurogenetic applications. Discover advanced workflow strategies, troubleshooting insights, and how this APExBIO master mix bridges bench research with translational breakthroughs.

• N1-Methyl-Pseudouridine-5'-Triphosphate in RNA Therapeutics

  2026-06-09

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) enhances RNA stability and translation, making it foundational in modern RNA therapeutics. Its methylated pseudouridine structure reduces immunogenicity and degradation, supporting mRNA vaccine and lung cancer immunotherapy research. Robust evidence demonstrates its superior performance over unmodified nucleotides in vitro and in vivo applications.

• Precision qPCR: HotStart™ Mix in Translational RNA Discovery

  2026-06-08

  This thought-leadership article explores the intersection of advanced qPCR chemistry and translational RNA research. By dissecting mechanistic and strategic insights, it guides researchers in leveraging HotStart™ 2X Green qPCR Master Mix for high-impact gene expression analysis, RNA-seq validation, and clinical innovation. Anchored by new antiviral discovery workflows, the article bridges experimental precision with real-world biomedical relevance.

• Sodium Ascorbate in Cancer Research: Protocols & Applied Ins

  2026-06-08

  Sodium Ascorbate, a mineral salt of ascorbic acid, drives selective tumor cell death via ROS induction—empowering robust glioblastoma and prostate cancer models. This review details optimized workflows, troubleshooting strategies, and translational use-cases for APExBIO’s high-purity Sodium Ascorbate.

• BCL-XL Inhibitor A-1155463: Precision Apoptosis in Cancer Mo

  2026-06-07

  A-1155463 empowers apoptosis induction in BCL-XL-dependent cell lines, outperforming previous inhibitors in potency and selectivity. This article details experimental workflows, protocol enhancements, and troubleshooting tips to unlock the full translational impact of this next-generation tool in cancer biology research.

• Nanobody Targeting of PstS-1 for TB Granuloma Imaging: Insig

  2026-06-06

  Dhekale et al. (2025) report the development of a camel-derived nanobody highly specific for the Mycobacterium tuberculosis protein PstS-1, a key antigen within the granulomatous lesions characteristic of tuberculosis. Their findings advance the potential for non-invasive, molecular imaging-based diagnostics targeting extrapulmonary and paucibacillary TB, where current diagnostic approaches are often insensitive.

• Engineered Nanozyme Therapy Restores Inflammation-Lipid Bala

  2026-06-05

  This study presents a multifunctional nanozyme platform, CPPS, that integrates drug delivery, enzyme-like ROS scavenging, and photothermal therapy to target atherosclerotic plaques. By restoring inflammation-lipid homeostasis, suppressing foam cell formation, and reducing plaque burden, the approach demonstrates a promising direction for comprehensive atherosclerosis therapy.

• Hesperadin: Aurora B Kinase Inhibitor for Mitotic Regulation

  2026-06-05

  Hesperadin is a potent ATP-competitive Aurora B kinase inhibitor that disrupts mitotic progression by blocking histone H3 phosphorylation and spindle assembly checkpoint fidelity. Its precise inhibition profile and robust cellular effects make it indispensable for advanced cell cycle and cancer research.

• TaqI Restriction Endonuclease: Fast DNA Digestion Protocols

  2026-06-04

  TaqI Restriction Endonuclease enables rapid, sequence-specific digestion of plasmid, PCR, or genomic DNA, accelerating workflows that require efficient DNA cleavage and sticky end generation. This product is optimized for research applications needing fast turnaround, but is not suitable for clinical or diagnostic use.

• OLIG2 Synthetic mRNA Enables Rapid hiPSC Differentiation to

  2026-06-04

  This study demonstrates a synthetic modified mRNA (smRNA) protocol for converting human-induced pluripotent stem cells (hiPSCs) into functional oligodendrocytes (OLs) without genome integration. By employing an OLIG2S147A smRNA and a rapid transfection protocol, the method offers a safer, efficient route for generating OL progenitors, with implications for cell-based therapy and disease modeling.

741 records 12/50 page Previous Next First page 上5页 1112131415 下5页 Last page